In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD

Danae A. Delivanis, Victor Manuel Montori

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)JC11
JournalAnnals of Internal Medicine
Volume162
Issue number8
StatePublished - Apr 21 2015

Fingerprint

Adamantane
Dipeptides
Type 2 Diabetes Mellitus
Hospitalization
Heart Failure
saxagliptin

ASJC Scopus subject areas

  • Internal Medicine

Cite this

In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD. / Delivanis, Danae A.; Montori, Victor Manuel.

In: Annals of Internal Medicine, Vol. 162, No. 8, 21.04.2015, p. JC11.

Research output: Contribution to journalArticle

@article{38484a7e92f447a6b6795d5f4a86799f,
title = "In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD",
author = "Delivanis, {Danae A.} and Montori, {Victor Manuel}",
year = "2015",
month = "4",
day = "21",
language = "English (US)",
volume = "162",
pages = "JC11",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "8",

}

TY - JOUR

T1 - In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD

AU - Delivanis, Danae A.

AU - Montori, Victor Manuel

PY - 2015/4/21

Y1 - 2015/4/21

UR - http://www.scopus.com/inward/record.url?scp=84928139306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928139306&partnerID=8YFLogxK

M3 - Article

C2 - 25894044

AN - SCOPUS:84928139306

VL - 162

SP - JC11

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 8

ER -